Apixaban in a Morbid Obese Patient With Atrial Fibrillation: A Clinical Experience Using the Plasmatic Drug Evaluation

Journal of Blood Medicine - New Zealand
doi 10.2147/jbm.s229526
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Informa UK Limited

Related search

Spontaneous Spinal Epidural Hematoma in a Patient on Apixaban for Nonvalvular Atrial Fibrillation

Case Reports in Hematology
2020English

Patient Satisfaction After Switching From Warfarin to Apixaban in Patients With Nonvalvular Atrial Fibrillation: AGAIN Study

Patient Preference and Adherence
PharmacologyHealth PolicyMedicineToxicologySocial SciencesPharmaceutics
2017English

Sudden Death in a Young Patient With Atrial Fibrillation

Cardiogenetics
2017English

Estimating the Lifetime Clinical Risk/Benefits of Apixaban Versus Edoxaban in Non-Valvular Atrial Fibrillation

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Appropriateness of Apixaban Dosing to Prevent Stroke in Patients With Atrial Fibrillation: A Pilot Study

Canadian Journal of Hospital Pharmacy
PharmacologyPharmacy
2016English

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Hemorrhagic Cerebral Venous Infarction in a Patient With Atrial Fibrillation:

Saudi Journal of Internal Medicine
2012English

Nocturnal Atrial Fibrillation in a Patient With Obstructive Sleep Apnoea

Thorax
PulmonaryRespiratory Medicine
2005English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy